We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Global Urinalysis Market to Reach USD 1.5 Billion by 2024

By LabMedica International staff writers
Posted on 31 Dec 2018
The global urinalysis market is expected to grow at a steady CAGR of 5.40% over the 2016-2024 period to reach a value of USD 1.5 billion by the end of 2024, propelled mainly by the rising incidence of diabetes and urinal infections, globally.

These are the latest findings of Transparency Market Research, (Albany, NY, USA), a global market intelligence company providing business information reports and services.

The global market for urinalysis is witnessing increased demand due to the heavy incidence of diabetes and urinal infections, which require quick treatment and can have severe consequences if left untreated. More...
Additionally, the increasing incidence of prostate cancer is also driving the demand in the global urinalysis market. The emergence of better and quicker means for urinalysis is expected to further aid the growth of the global urinalysis market over the coming years.

Based on test setting, the laboratory-based segment dominates the urinalysis market and is expected to maintain its leading position during the forecast period due to the growing geriatric population, unhealthy lifestyles, and rising incidence of infectious diseases globally. On the basis of type of test, the biochemical segment leads the urinalysis market, on account of the widely accepted usage of dipsticks (reagent strips) that detect the presence of constituents in urine. The technique is also convenient to operate as it is readily available. Based on end-user, the hospital segment dominates the global urinalysis market. On the basis of product, the consumables segment leads the global urinalysis market due to the high rate of acceptance of single-use, rigid, and sterile disposable products. Within the consumables segment, plastic consumables are expected to provide immense growth opportunities.

Geographically, North America led the global urinalysis market in 2015 with the highest share of 30.0%, driven by the high number of kidney patients and increasing incidence of urinary tract infections in the country. The urinalysis market in Latin America is expected to register an impressive CAGR during the forecast period, led by favorable government policies, and the region’s massive population base and large patient pool.

Asia Pacific is expected to become a major market for urinalysis and provide lucrative growth opportunities, with Japan dominating the region due to its increasing aging population, rapid industrialization, growing number of laboratory diagnosis tests, and high adoption of point-of-care testing. India and China are also expected to contribute significantly to the growth the urinalysis market in Asia Pacific on account of numerous infrastructural development projects.

However, various factors are hampering the demand in the global urinalysis market. Incidences of faulty analysis of urine samples have negatively impacted the performance and competency of diagnostic centers. This is expected to significantly hamper the growth of the global urinalysis market. However, the need to conduct urine analysis and prescription of urine tests by medical specialists will continue to aid the market growth.

The players in the global urinalysis market have adopted various strategies to expand their consumer base, including research and development. These players are now focusing on providing errorless analysis and testing of urine, as well as reducing the time taken for analysis and research. The companies are also incorporating safer and more hygienic standards for conducting urinalysis. With the global market for urinalysis being directly related to the medical and healthcare industries, the market vendors are collaborating with hospitals and healthcare centers. Referrals from hospitals and healthcare centers play a key role in enhancing the growth prospects of these vendors. The global urinalysis market is expected to witness multiple mergers, strategic partnerships, and acquisitions over the coming years.

Related Links:
Transparency Market Research


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Staining System
RAL DIFF-QUIK
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.